Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

1.

IRAK-4 mutation (Q293X): rapid detection and characterization of defective post-transcriptional TLR/IL-1R responses in human myeloid and non-myeloid cells.

Davidson DJ, Currie AJ, Bowdish DM, Brown KL, Rosenberger CM, Ma RC, Bylund J, Campsall PA, Puel A, Picard C, Casanova JL, Turvey SE, Hancock RE, Devon RS, Speert DP.

J Immunol. 2006 Dec 1;177(11):8202-11.

PMID:
17114497
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Experimental and natural infections in MyD88- and IRAK-4-deficient mice and humans.

von Bernuth H, Picard C, Puel A, Casanova JL.

Eur J Immunol. 2012 Dec;42(12):3126-35. doi: 10.1002/eji.201242683. Review.

PMID:
23255009
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family.

Martin MU, Wesche H.

Biochim Biophys Acta. 2002 Nov 11;1592(3):265-80. Review.

PMID:
12421671
[PubMed - indexed for MEDLINE]
Free Article
4.

MicroRNA in TLR signaling and endotoxin tolerance.

Nahid MA, Satoh M, Chan EK.

Cell Mol Immunol. 2011 Sep;8(5):388-403. doi: 10.1038/cmi.2011.26. Epub 2011 Aug 8. Review.

PMID:
21822296
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency.

Picard C, Casanova JL, Puel A.

Clin Microbiol Rev. 2011 Jul;24(3):490-7. doi: 10.1128/CMR.00001-11. Review.

PMID:
21734245
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Targeting TLR/IL-1R signalling in human diseases.

Loiarro M, Ruggiero V, Sette C.

Mediators Inflamm. 2010;2010:674363. doi: 10.1155/2010/674363. Epub 2010 Apr 8. Review.

PMID:
20396389
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

IL-1, IL-18, and IL-33 families of cytokines.

Arend WP, Palmer G, Gabay C.

Immunol Rev. 2008 Jun;223:20-38. doi: 10.1111/j.1600-065X.2008.00624.x. Review.

PMID:
18613828
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk